NCT07129902View on ClinicalTrials.gov

Contingency Management to Improve Medication for Opioid Use Disorder Continuation After the Emergency Department

NANot yet recruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

September 1, 2025

Primary Completion Date

October 1, 2026

Study Completion Date

October 31, 2026

Conditions
Opioid Use Disorder
Interventions
BEHAVIORAL

Contingency Management

Participants in the active arm will receive payment (monetary incentive) contingent on outpatient MOUD treatment attendance.

BEHAVIORAL

Usual care as prescribed by the ED physicians

All participants will receive standard outpatient care at their clinic.

Trial Locations (1)

05405

University of Vermont Medical Center, Burlington

All Listed Sponsors
collaborator

National Institute of General Medical Sciences (NIGMS)

NIH

lead

University of Vermont

OTHER

NCT07129902 - Contingency Management to Improve Medication for Opioid Use Disorder Continuation After the Emergency Department | Biotech Hunter | Biotech Hunter